Merck & Co. Inc., Pfizer Inc., and Eli Lilly and Company announced medical service volunteer programs to enable employees who are licensed medical professionals to aid in the fight against COVID-19 while maintaining their base pay.

A summary of daily biopharma industry news regarding the novel coronavirus trending on March 27, 2020, with the FDA now working with 220 test developers.

As a critical industry during the COVID-19 pandemic, biopharma companies are expected to remain in operation – but with a skeleton staff. Anticipating stay-at-home mandates, life sciences companies and labs in especially hard-hit regions had already begun preparing.

U.S. Vice President Mike Pence promised that Americans would have access in the days ahead to more than 2,000 laboratories capable of processing coronavirus tests, and a leading expert said the country would launch a new phase of testing for the fast-spreading disease.

Companies from across the globe provide updates on their business and pipeline progress.

Theranos reportedly failed to notify patients in Arizona about potentially deficient diabetes tests.

U.S. federal health regulators have proposed banning Theranos Inc founder Elizabeth Holmes from the blood-testing business for at least two years after determining that the company failed to fix deficiencies at its California laboratory, the Wall Street Journal reported on Wednesday. The Centers for Medicare and Medicaid (CMS) said in letter dated March 18 that […]

Lonza to Host Free Webinar on Integrated QC Processes and Data Integrity   Walkersville, MD, USA / Cologne, Germany, 16 October 2015 – Lonza has announced that it will host a free 60-minute webinar on 3 November 2015 titled “The Integrated QC Micro Lab and Data Integrity.” It will provide details about how laboratory professionals […]